OBJECTIVE: The highly infiltrative growth of glioblastoma (GBM) makes distinction between the tumor and normal brain tissue challenging. Therefore, fluorescence-guided surgery is often used to improve visual identification of radiological tumor margins. The aim of this study was to evaluate the ability of recently developed molecularly targeted near-infrared (NIR) protease-activated probes to visualize GBM tissue and to compare the most promising candidate with the gold standard, 5-aminolevulinic acid (5-ALA). METHODS: Single-substrate probes 6QC-ICG and 6QC-Cy5 (cysteine cathepsin cleavable), double-substrate probes AG2-FNIR and AG2-Cy5 (cysteine cathepsin and caspase 3 cleavable), and 5-ALA were administered intravenously to mice with orthotopic tumors. Activation of the probes was also evaluated in cell cultures in vitro and in biopsy material from patients with GBM ex vivo. The tumor to normal brain tissue fluorescence ratio (TNR) was quantified in brain sections using preclinical and clinical visualization platforms, and in tissue homogenates and cell suspensions using spectrofluorimetry. Subcellular localization of the fluorophores was visualized by confocal microscopy. RESULTS: In vitro, the single-substrate probe 6QC-ICG was cleaved in glioma cells and macrophages, and the resulting fluorophore accumulated intracellularly. In experimental GBMs, both single- and double-substrate probes visualized tumor tissue, while in healthy brain tissue the signal was minimal. TNR was highest for 6QC-ICG and AG2-FNIR, but the signal intensity was higher for 6QC-ICG. Using xenograft and syngeneic mouse models, as well as human GBM biopsy material ex vivo, the authors confirmed the ability of 6QC-ICG to specifically visualize the glioma tissue using preclinical and clinical visualization platforms. Finally, a comparison with 5-ALA in animals coadministered with both compounds revealed a higher TNR for 6QC-ICG in experimental GBMs. CONCLUSIONS: The cysteine cathepsin-cleavable probe 6QC-ICG is activated by glioma cells and tumor-associated macrophages, leading to a high contrast between tumor and nontumorous brain tissue that is superior to that of the current standard, 5-ALA. In addition to a well-defined mechanism of action, protease-activated probes that use NIR fluorophores (e.g., indocyanine green) have the advantage of low absorption and scattering of the NIR light and lower tissue autofluorescence. These results suggest that 6QC-ICG has the potential to become the targeted agent in intraoperative detection of GBM tissue using fluorescence imaging.

Center of Advanced Preclinical Imaging 1st Faculty of Medicine Charles University Prague Czech Republic; and

Department of Neurosurgery and Neurooncology 1st Faculty of Medicine and Military University Hospital Prague

Department of Pathology Stanford University School of Medicine Stanford California

Institute of Biochemistry and Experimental Oncology 1st Faculty of Medicine Charles University Prague

Institute of Information Theory and Automation Czech Academy of Sciences Prague

Zobrazit více v PubMed

Simpson JR, Horton J, Scott C, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys. 1993;26(2):239–244. PubMed

Pallud J, Varlet P, Devaux B, et al. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurology. 2010;74(21):1724–1731. PubMed

Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection? J Neurosurg. 2016;124(4):977–988. PubMed

Duffau H. Is supratotal resection of glioblastoma in noneloquent areas possible? World Neurosurg. 2014;82(1-2):e101–e103. PubMed

Khalafallah AM, Rakovec M, Bettegowda C, et al. A crowdsourced consensus on supratotal resection versus gross total resection for anatomically distinct primary glioblastoma. Neurosurgery. 2021;89(4):712–719. PubMed PMC

Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62(3):564–576. PubMed

Willems PWA, Taphoorn MJB, Burger H, Berkelbach van der Sprenkel JW, Tulleken CA. Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial. J Neurosurg. 2006;104(3):360–368. PubMed

Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol. 2011;12(11):997–1003. PubMed

Ishikawa M, Masamoto K, Hachiya R, et al. Neurosurgical intraoperative ultrasonography using contrast enhanced superb microvascular imaging-vessel density and appearance time of the contrast agent. Br J Neurosurg. 2023;37(3):485–494. PubMed

Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93(6):1003–1013. PubMed

Schupper AJ, Baron RB, Cheung W. 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study. J Neurosurg. 2021;136(6):1525–1534. et al. PubMed

Traylor JI, Pernik MN, Sternisha AC, McBrayer SK, Abdullah KG. Molecular and metabolic mechanisms underlying selective 5-aminolevulinic acid-induced fluorescence in gliomas. Cancers (Basel) 2021;13(3):580. PubMed PMC

Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392–401. PubMed

Hadjipanayis CG, Widhalm G, Stummer W. What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas? Neurosurgery. 2015;77(5):663–673. PubMed PMC

Masubuchi T, Kajimoto Y, Kawabata S, et al. Experimental study to understand nonspecific protoporphyrin IX fluorescence in brain tissues near tumors after 5-aminolevulinic acid administration. Photomed Laser Surg. 2013;31(9):428–433. PubMed

Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 1998;42(3):518–526. PubMed

Lee JYK, Thawani JP, Pierce J, et al. Intraoperative near-infrared optical imaging can localize gadolinium-enhancing gliomas during surgery. Neurosurgery. 2016;79(6):856–871. PubMed PMC

Cho SS, Sheikh S, Teng CW, et al. Evaluation of diagnostic accuracy following the coadministration of delta-aminolevulinic acid and second window indocyanine green in rodent and human glioblastomas. Mol Imaging Biol. 2020;22(5):1266–1279. PubMed PMC

Napier TS, Udayakumar N, Jani AH, et al. Comparison of panitumumab-IRDye800CW and 5-aminolevulinic acid to provide optical contrast in a model of glioblastoma multiforme. Mol Cancer Ther. 2020;19(9):1922–1929. PubMed PMC

Warram JM, de Boer E, Korb M, et al. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. Br J Neurosurg. 2015;29(6):850–858. PubMed PMC

Huang R, Vider J, Kovar JL, et al. Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res. 2012;18(20):5731–5740. PubMed PMC

Widen JC, Tholen M, Yim JJ. AND-gate contrast agents for enhanced fluorescence-guided surgery. Nat Biomed Eng. 2021;5(3):264–277. et al. PubMed PMC

Yim JJ, Tholen M, Klaassen A, Sorger J, Bogyo M. Optimization of a protease activated probe for optical surgical navigation. Mol Pharm. 2018;15(3):750–758. PubMed

Widen JC, Tholen M, Yim JJ, Bogyo M. Methods for analysis of near-infrared (NIR) quenched-fluorescent contrast agents in mouse models of cancer. Methods Enzymol. 2020;639:141–166. PubMed

Gole B, Huszthy PC, Popović M. The regulation of cysteine cathepsins and cystatins in human gliomas. Int J Cancer. 2012;131(8):1779–1789. et al. PubMed

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–1251. PubMed PMC

Sana J, Busek P, Fadrus P, et al. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Sci Rep. 2018;8(1):2836. PubMed PMC

Busek P, Stremenova J, Sromova L, et al. Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity. Int J Biochem Cell Biol. 2012;44(5):738–747. PubMed

Swanson KI, Clark PA, Zhang RR, et al. Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection. Neurosurgery. 2015;76(2):115–124. PubMed PMC

Balaziova E, Vymola P, Hrabal P, et al. Fibroblast activation protein expressing mesenchymal cells promote glioblastoma angiogenesis. Cancers (Basel) 2021;13(13):3304. PubMed PMC

Ofori LO, Withana NP, Prestwood TR, et al. Design of protease activated optical contrast agents that exploit a latent lysosomotropic effect for use in fluorescence-guided surgery. ACS Chem Biol. 2015;10(9):1977–1988. PubMed PMC

Szatmári T, Lumniczky K, Désaknai S, et al. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci. 2006;97(6):546–553. PubMed PMC

Jiao J, Zhang J, Yang F, et al. Quicker, deeper and stronger imaging: a review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages. Eur J Pharm Biopharm. 2020;152:123–143. PubMed

Brennan CW, Verhaak RGW, McKenna A. The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462–477. et al. PubMed PMC

Veiseh M, Gabikian P, Bahrami SB. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. 2007;67(14):6882–6888. et al. PubMed

Li L, Du Y, Chen X, Tian J. Fluorescence molecular imaging and tomography of matrix metalloproteinase-activatable near-infrared fluorescence probe and image-guided orthotopic glioma resection. Mol Imaging Biol. 2018;20(6):930–939. PubMed

Sarkaria JN, Hu LS, Parney IF, et al. Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol. 2018;20(2):184–191. PubMed PMC

Cutter JL, Cohen NT, Wang J, et al. Topical application of activity-based probes for visualization of brain tumor tissue. PLoS One. 2012;7(3):e33060. PubMed PMC

Hu D, Jiang Y, Belykh E, et al. Toward real-time tumor margin identification in image-guided robotic brain tumor resection. Proc SPIE Int Soc Opt Eng. 2017;10135:101350D. PubMed PMC

Cho SS, Teng CW, De Ravin E, Singh YB, Lee JYK. Assessment and comparison of three dimensional exoscopes for near-infrared fluorescence-guided surgery using second-window indocyanine-green. J Korean Neurosurg Soc. 2022;65(4):572–581. PubMed PMC

Yim JJ, Harmsen S, Flisikowski K, et al. A protease-activated, near-infrared fluorescent probe for early endoscopic detection of premalignant gastrointestinal lesions. Proc Natl Acad Sci U S A. 2021;118(1):e2008072118. PubMed PMC

Valdes PA, Juvekar P, Agar NYR, Gioux S, Golby AJ. Quantitative wide-field imaging techniques for fluorescence guided neurosurgery. Front Surg. 2019;6(31):31. PubMed PMC